Trial | NCT04542876  Report issue

Title

Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection: An Open Label Feasibility Study

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    46
The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemic.There have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditions.Therefore, present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19
Study Started
May 01
2020
Primary Completion
Jul 31
2020
Study Completion
Aug 18
2020
Last Update
Sep 09
2020

Drug Guduchi Ghan Vati

Guduchi Ghan Vati was orally administered 2 tablets (1000 mg) twice daily for 2 weeks.

  • Other names: Giloya, Amrita, Tinosporia Cordifolus, Guduchi

Ayurveda Experimental

Guduchi Ghana is a unique Ayuvedic classical preparation prepared from aqueous extracts of Tinospora cordifolia stem.

Criteria 

Inclusion Criteria:

All hospitalised cases above 18 years of age,
Diagnosed with Covid-19
Asymptomatic at the time of admission
Agree to give consent

Exclusion Criteria:

Symptoms relating to Covid-19
Severe vomiting
Respiratory failure or requiring mechanical ventilation
Patients having alanine transaminase (ALT) or aspartate transaminase (AST) > 5 times the upper range of normal limits
Patients with Covid-19 in critical condition or ARDS or NIAD 8 -point ordinal score-2
Patients with uncontrolled diabetes mellitus
Malignant,
Chronic renal failure or
On immunosuppressive medication
No Results Posted